Immediate Impact
54 standout
Citing Papers
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Katy White being referenced
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Katy White | 173 | 49 | 94 | 172 | 13 | 407 | |
| Jennifer Hughes | 50 | 20 | 109 | 111 | 8 | 412 | |
| Emanuela Zagni | 55 | 98 | 35 | 18 | 16 | 397 | |
| D Golan | 158 | 84 | 10 | 37 | 12 | 345 | |
| Susan Gabriel | 31 | 85 | 41 | 56 | 10 | 378 | |
| V. L. Beckett | 35 | 27 | 57 | 20 | 12 | 336 | |
| Kuo‐You Huang | 22 | 12 | 29 | 28 | 22 | 351 | |
| David Hägg | 219 | 46 | 109 | 9 | 17 | 417 | |
| J.D. Pearson | 18 | 19 | 14 | 161 | 12 | 348 | |
| Netta Shoenfeld | 40 | 63 | 14 | 49 | 18 | 377 | |
| C. Davoli | 93 | 166 | 13 | 17 | 22 | 423 |
All Works
Login with ORCID to disown or claim papers
Loading papers...